Svenska Handelsbanken’s AbbVie ABBV Stock Holding History

Svenska Handelsbanken’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-182,749	Closed	-$33.3M	–	14
2024 Q1	$33.3M	Buy	+182,749	New	+$31.5M	10.49%	2
2021 Q4	–	Sell	-2,578	Closed	-$278K	–	10
2021 Q3	$278K	Buy	+2,578	New	+$295K	1.49%	10
2019 Q1	–	Sell	-10,300	Closed	-$950K	–	46
2018 Q4	$950K	Hold	10,300	–	–	1.42%	34
2018 Q3	$974K	Hold	10,300	–	–	1.25%	37
2018 Q2	$954K	Sell	10,300 -3,800	-27%	-$371K	1.36%	36
2018 Q1	$1.33M	Hold	14,100	–	–	1.9%	24
2017 Q4	$1.36M	Hold	14,100	–	–	1.84%	25
2017 Q3	$1.25M	Hold	14,100	–	–	1.7%	31
2017 Q2	$1.02M	Hold	14,100	–	–	1.54%	28
2017 Q1	$919K	Buy	14,100 +4,900	+53%	+$308K	1.23%	30
2016 Q4	$576K	Hold	9,200	–	–	0.03%	47
2016 Q3	$580K	Hold	9,200	–	–	0.05%	73
2016 Q2	$570K	Sell	9,200 -547,365	-98%	-$33.4M	0.03%	88
2016 Q1	$31.8M	Sell	556,565 -952,635	-63%	-$53.1M	3.42%	10
2015 Q4	$89.4M	Buy	+1,509,200	New	+$86.9M	9.02%	6

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Svenska Handelsbanken's ABBV Position: Q2 2024 in Review

Svenska Handelsbanken sold out of AbbVie (ABBV) in Q2 2024, closing a stake of 182,749 shares — an estimated $33.3M sold.

Svenska Handelsbanken first reported a position in ABBV in Q4 2015 and held it in 15 quarters. The position peaked at $89.4M in Q4 2015. 3,365 funds tracked by Wall St. Rank hold ABBV as of Q2 2024.

Svenska Handelsbanken reported no remaining AbbVie position as of Q2 2024 after selling out during the quarter.
Svenska Handelsbanken sold 182,749 AbbVie shares in Q2 2024, an estimated $33.3M.
Svenska Handelsbanken first reported a position in AbbVie in Q4 2015 and held it in 15 quarters.
Svenska Handelsbanken's AbbVie position peaked at $89.4M in Q4 2015.
3,365 funds tracked by Wall St. Rank held AbbVie as of Q2 2024.

Based on Svenska Handelsbanken's 13F filing for Q2 2024, filed 10 Jul 2024.